Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT)

被引：0
|
作者：
T. S. Armstrong
T. Mendoza
I. Gning
C. Coco
M. Z. Cohen
L. Eriksen
Ming-Ann Hsu
M. R. Gilbert
C. Cleeland
机构：
[1] The University of Texas Health Science Center at Houston,
[2] School of Nursing,undefined
[3] The University of Texas M.D. Anderson Cancer Center,undefined
[4] Pfizer,undefined
[5] Inc.,undefined
[6] Neuro-Oncology,undefined
[7] Unit 431,undefined
[8] UT MDACC,undefined
来源：
Journal of Neuro-Oncology | 2006年 / 80卷 / 1期
关键词：
D O I：
10.1007/s11060-006-9228-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：37 / 37
相关论文
共 50 条
  • [1] Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT)
    T.S. Armstrong
    T. Mendoza
    I. Gring
    C. Coco
    M.Z. Cohen
    L. Eriksen
    Ming-Ann Hsu
    M.R. Gilbert
    C. Cleeland
    [J]. Journal of Neuro-Oncology, 2006, 80 : 27 - 35
  • [2] Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT)
    Armstrong, T. S.
    Mendoza, T.
    Gring, I.
    Coco, C.
    Cohen, M. Z.
    Eriksen, L.
    Hsu, Ming-Ann
    Gilbert, M. R.
    Cleeland, C.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2006, 80 (01) : 27 - +
  • [3] Validation of the MD Anderson symptom inventory brain tumor module (MDASI-BT)
    Armstrong, T. S.
    Mendoza, T.
    Gring, I.
    Coco, C.
    Cohen, M. Z.
    Eriksen, L.
    Hsu, M. A.
    Gilbert, M. R.
    Cleeland, C.
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 474 - 475
  • [4] Reliability and validity of the M.D. Anderson symptom inventory (MDASI-BT) in the primary brain tumor patient population
    Armstrong, TS
    Mendoza, T
    Cohen, MZ
    Morrissey, M
    Gilbert, MR
    Cleeland, C
    [J]. NEURO-ONCOLOGY, 2004, 6 (04) : 355 - 356
  • [5] Validation of the M. D. Anderson symptom inventory (MDASI-BT).
    Armstrong, T. S.
    Mendoza, T.
    Gning, I.
    Coco, C.
    Gilbert, M. R.
    Cleeland, C.
    Cohen, M. Z.
    Eriksen, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 69S - 69S
  • [6] Reliability and validity of the M.D. Anderson symptom inventory (MDASI-BT) in the primary brain tumor patient population.
    Armstrong, T
    Mendoza, T
    Cohen, M
    Morrissey, M
    Cleeland, C
    Gilbert, M
    [J]. ONCOLOGY NURSING FORUM, 2005, 32 (02) : 476 - 477
  • [7] The Impact of Symptom Interference Using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on Prediction of Recurrence in Primary Brain Tumor Patients
    Armstrong, Terri S.
    Vera-Bolanos, Elizabeth
    Gning, Ibrahima
    Acquaye, Alvina
    Gilbert, Mark R.
    Cleeland, Charles
    Mendoza, Tito
    [J]. CANCER, 2011, 117 (14) : 3222 - 3228
  • [8] THE IMPACT OF SYMPTOM INTERFERENCE USING THE MD ANDERSON SYMPTOM INVENTORY-BRAIN TUMOR MODULE (MDASI-BT) ON PREDICTION OF RECURRENCE IN PRIMARY BRAIN TUMOR PATIENTS
    Armstrong, Terri
    Vera-Bolanos, Elizabeth
    Gning, Ibrahima
    Acquaye, Alvina
    Gilbert, Mark R.
    Cleeland, Charles
    Mendoza, Tito R.
    [J]. NEURO-ONCOLOGY, 2010, 12 : 103 - 103
  • [9] VALIDATION OF THE M. D. ANDERSON SYMPTOM INVENTORY SPINE TUMOR MODULE (MDASI-SP)
    Armstrong, Terri
    Gning, Ibrahima
    Mendoza, Tito
    Vera, Elizabeth
    Gilbert, Mark
    Rhines, Laurence
    Weinberg, Jeffrey
    Sanchez-Williams, Gisella
    Levin, Victor
    Burton, Allen
    Grossman, Tracy
    Cleeland, Charles
    [J]. NEURO-ONCOLOGY, 2008, 10 (05) : 876 - 876
  • [10] ASSESSING THE VALIDITY OF THE MD ANDERSON SYMPTOM INVENTORY-BRAIN TUMOR (MDASI-BT) USING CAREGIVER PROXY REPORT
    Gning, Ibrahima
    Armstrong, Terri S.
    Wefel, Jeffrey S.
    Acquaye, Alvina A.
    Vera-Bolanos, Elizabeth
    Mendoza, Tito R.
    Gilbert, Mark R.
    Cleeland, Charles S.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 158 - 158
12345